Home Potential biomarkers of ASD a target for future treatments: oxidative stress, chemokines, apoptotic, and methylation capacity
Article
Licensed
Unlicensed Requires Authentication

Potential biomarkers of ASD a target for future treatments: oxidative stress, chemokines, apoptotic, and methylation capacity

  • Moushira Zaki ORCID logo EMAIL logo , Eman R. Youness , Hisham A. Orban , Hend M. Ahmed , Rehab S.I. Moustafa , Fatma A. Alzaree , Engy A. Ashaat and Hala T. El-Bassyouni ORCID logo
Published/Copyright: July 4, 2024

Abstract

Objectives

The study aimed to assess the effect of these biomarkers on a sample of children with autism spectrum disorder (ASD) to help in early diagnosis and intervention.

Methods

A total of 71 autistic patients and 65 normal controls were enrolled in this study. Their ages ranged from 5 to 11 years (mean ± SD 7.47 ± 3.81). Childhood Autism Rating Scale (CARS) was assessed for all patients and controls. Assessment of oxidative stress, monocyte chemoattractant protein-1, B-cell lymphoma 2, S-adenosylhomocysteine (SAH), and apelin was performed.

Results

Oxidative stress (oxidized low-density lipoprotein and malonaldehyde) increased while antioxidant paraoxonase (PON) decreased. Monocyte chemoattractant protein-1, B-cell lymphoma 2, and S-adenosylhomocysteine (SAH) were all elevated whereas, apelin was downregulated.

Conclusions

It is important to note that many factors that may contribute to ASD including genetic factors. To open the door for novel treatment strategies, it is still necessary to precisely understand how oxidative stress, chemokines, apoptosis, and methylation capability affect the metabolism of people with ASD.


Corresponding author: Moushira Zaki, Biological Anthropology Department, Medical Research and Clinical Studies Institute–National Research Centre Cairo, Cairo, Egypt, E-mail:

Acknowledgment

We thank all the participants.

  1. Research ethics: The lab protocols and recruitment practices used in the study were in compliance with the Declaration of Helsinki, according to a certification issued by the National Research Centre Ethical Research Committee (number 2-2-0, 02/2023).

  2. Informed consent: Not applicable.

  3. Author contributions: MZ conceived the study; RM and AA, EA collected the data; ERY, HO, HA ERY did the biochemical analysis. MZ and HB wrote, reviewed, and proofread the final manuscript.

  4. Competing interests: The authors state no conflict of interest.

  5. Research funding: None declared.

  6. Data availability: The authors can provide the materials and data used in this study upon request.

References

1. Bennett, AE, Miller, JS, Stollon, N, Prasad, R, Blum, NJ. Autism spectrum disorder and transition-aged youth. Curr Psychiatr Rep 2018;20:1–9. https://doi.org/10.1007/s11920-018-0967-y.Search in Google Scholar PubMed

2. Mahdi, S, Viljoen, M, Yee, T, Selb, M, Singhal, N, Almodayfer, O, et al.. An international qualitative study of functioning in autism spectrum disorder using the World Health Organization international classification of functioning, disability and health framework. Autism Res 2018;11:463–75. https://doi.org/10.1002/aur.1905.Search in Google Scholar PubMed PubMed Central

3. Peng, G, Peng, X, Tong, T, Zhang, X, Xu, M, Peng, X. Correlation analysis of expression of CC and CXC chemokines in children with autism spectrum disorder. Medicine (Baltimore) 2021;100:e26391-1–5.10.1097/MD.0000000000026391Search in Google Scholar PubMed PubMed Central

4. El-Bassyouni, HT, Ismail, SI, El-Saeed, GSM, Alghroury, EA, Abd El Dayem, SM. Assessment of metal content and oxidative stress in autistic Egyptian patients. Middle East J Med Genet 2013;2:23–7. https://doi.org/10.1097/01.mxe.0000422775.82611.a3.Search in Google Scholar

5. Liu, X, Lin, J, Zhang, H, Khan, NU, Zhang, J, Tang, X, et al.. Oxidative stress in autism spectrum disorder – current progress of mechanisms and biomarkers. Front Psychiatry 2022;13:813304–1–20. https://doi.org/10.3389/fpsyt.2022.813304.Search in Google Scholar PubMed PubMed Central

6. Yui, K, Imataka, G, Sasaki, H, Shiroki, R, Koshiba, M. Lipid peroxidation with implication of organic pollution in autistic behaviors. Cureus 2021;13:1–9. https://doi.org/10.7759/cureus.14188.Search in Google Scholar PubMed PubMed Central

7. Xu, B, Lang, L-M, Lian, S, Guo, J-R, Wang, J-F, Yang, H-M, et al.. Oxidation stress-mediated MAPK signaling pathway activation induces neuronal loss in the CA1 and CA3 regions of the hippocampus of mice following chronic cold exposure. Brain Sci 2019;9:273. https://doi.org/10.3390/brainsci9100273.Search in Google Scholar PubMed PubMed Central

8. Zaki, M, El-Bassyouni, HT, Hamed, K, Moustafa, RSI, Youness, ER. Brain derived neurotrophic factor, oxidative stress status and vitamin D levels in patients with autism spectrum disorder. New Zeal J Med Lab Sci. 2022;76:10–3.Search in Google Scholar

9. Huen, K, Solomon, O, Kogut, K, Eskenazi, B, Holland, N. PON1 DNA methylation and neurobehavior in Mexican-American children with prenatal organophosphate exposure. Environ Int 2018;121:31–40. https://doi.org/10.1016/j.envint.2018.08.044.Search in Google Scholar PubMed PubMed Central

10. Liu, M, Chen, Y, Sun, M, Du, Y, Bai, Y, Lei, G, et al.. Auts2 regulated autism-like behavior, glucose metabolism and oxidative stress in mice. Exp Neurol 2023;361: https://doi.org/10.1016/j.expneurol.2022.114298.Search in Google Scholar PubMed

11. Maldonado-Ruiz, R, Trujillo-Villarreal, LA, Montalvo-Martínez, L, Mercado-Gómez, OF, Arriaga-Ávila, V, Garza-Ocañas, L, et al.. MCP-1 signaling disrupts social behavior by modulating brain volumetric changes and microglia morphology. Mol Neurobiol 2022;59:1–18. https://doi.org/10.1007/s12035-021-02649-7.Search in Google Scholar PubMed

12. Han, VX, Patel, S, Jones, HF, Nielsen, TC, Mohammad, SS, Hofer, MJ, et al.. Maternal acute and chronic inflammation in pregnancy is associated with common neurodevelopmental disorders: a systematic review. Transl Psychiatry 2021;11:71. https://doi.org/10.1038/s41398-021-01198-w.Search in Google Scholar PubMed PubMed Central

13. Zhang, J, Liu, L-M, Ni, J-F. Rapamycin modulated brain-derived neurotrophic factor and B-cell lymphoma 2 to mitigate autism spectrum disorder in rats. Neuropsychiatr Dis Treat 2017;13:835–42. https://doi.org/10.2147/ndt.s125088.Search in Google Scholar

14. Rossignol, DA, Frye, RE. The effectiveness of cobalamin (B12) treatment for autism spectrum disorder: a systematic review and meta-analysis. J Pers Med 2021;11:784. https://doi.org/10.3390/jpm11080784.Search in Google Scholar PubMed PubMed Central

15. Guo, B, Ding, S, Li, H. Blood biomarker levels of methylation capacity in autism spectrum disorder: a systematic review and meta-analysis. Acta Psychiatr Scand 2020;141:492–509. https://doi.org/10.1111/acps.13170.Search in Google Scholar PubMed

16. Boso, M, Emanuele, E, Politi, P, Pace, A, Arra, M, di Nemi, SU, et al.. Reduced plasma apelin levels in patients with autistic spectrum disorder. Arch Med Res 2007;38:70–4. https://doi.org/10.1016/j.arcmed.2006.08.003.Search in Google Scholar PubMed

17. Schopler, E, Reichler, RJ, DeVellis, RF, Daly, K. Toward objective classification of childhood autism: childhood autism rating scale (CARS). J Autism Dev Disord 1980;10:91–103. https://doi.org/10.1007/bf02408436.Search in Google Scholar PubMed

18. Ruiz-Larrea, MB, Leal, AM, Liza, M, Lacort, M, de Groot, H. Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes. Steroids 1994;59:383–8. https://doi.org/10.1016/0039-128x(94)90006-x.Search in Google Scholar PubMed

19. Haagen, L, Brock, A. A new automated method for phenotyping arylesterase (EC 3.1. 1.2) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clin Biochem. 1992;30:391–5.10.1515/cclm.1992.30.7.391Search in Google Scholar PubMed

20. Thongkorn, S, Kanlayaprasit, S, Kasitipradit, K, Lertpeerapan, P, Panjabud, P, Hu, VW, et al.. Investigation of autism-related transcription factors underlying sex differences in the effects of bisphenol a on transcriptome profiles and synaptogenesis in the offspring hippocampus. Biol Sex Differ 2023;14:1–27. https://doi.org/10.1186/s13293-023-00496-w.Search in Google Scholar PubMed PubMed Central

21. Roy, N, Ghaziuddin, M, Mohiuddin, S. Consanguinity and autism. Curr Psychiatr Rep 2020;22:1–6. https://doi.org/10.1007/s11920-019-1124-y.Search in Google Scholar PubMed

22. Feng, C, Chen, Y, Pan, J, Yang, A, Niu, L, Min, J, et al.. Redox proteomic identification of carbonylated proteins in autism plasma: insight into oxidative stress and its related biomarkers in autism. Clin Proteonomics 2017;14:1–8. https://doi.org/10.1186/s12014-017-9138-0.Search in Google Scholar PubMed PubMed Central

23. Deshmane, SL, Kremlev, S, Amini, S, Sawaya, BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interf Cytokine Res 2009;29:313–26. https://doi.org/10.1089/jir.2008.0027.Search in Google Scholar PubMed PubMed Central

24. Fatemi, SH, Halt, AR, Stary, JM, Realmuto, GM, Jalali-Mousavi, M. Reduction in anti-apoptotic protein Bcl-2 in autistic cerebellum. Neuroreport 2001;12:929–33. https://doi.org/10.1097/00001756-200104170-00013.Search in Google Scholar PubMed

25. Scott, SR, Millwood, SN, Manczak, EM. Adipocytokine correlates of childhood and adolescent mental health: a systematic review. Dev Psychobiol 2023;65:e22379. https://doi.org/10.1002/dev.22379.Search in Google Scholar PubMed

26. Qassim Jawad, S, AL-Rubaee, EA, Ali, IA. Assessment of the levels of vasopressin and androgen in the sample of Iraqi children with autism spectrum disorder. Cell Mol Biol Res 2024;4:111–9. https://doi.org/10.55705/cmbr.2023.404612.1159.Search in Google Scholar

Received: 2024-04-29
Accepted: 2024-06-17
Published Online: 2024-07-04

© 2024 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Reviews
  3. Boldine: a narrative review of the bioactive compound with versatile biological and pharmacological potential
  4. Potential anti-cancer activity of Moringa oleifera derived bio-active compounds targeting hypoxia-inducible factor-1 alpha in breast cancer
  5. Research Articles
  6. Phytochemical characterisation and toxicity effect of Tithonia diversifolia (Hemls.) A. Gray leaf extract on fall army worm Spodoptera frugiperda (JE Smith) larvae
  7. Management of wounds in diabetes by administering allicin and quercetin in emulsion form as wound medicine in diabetic rat models
  8. Evaluation of anti-nociceptive and anti-inflammatory activities of solvent fraction of the roots of Echinops kebericho Mesfin (Asteraceae) in mice model
  9. A spectrometric analysis of variedly purified cinnabar in a siddha drug – linga chendhooram
  10. Palm oil amends serum female hormones, ovarian antioxidants, inflammatory markers, and DNA fragmentation in favism-induced female rats
  11. Brazil nuts potential: effects on lipid peroxidation and heart health in nephrectomized rats
  12. Preclinical antidiabetic and antioxidant effects of Erythrophleum africanum (benth.) harms in streptozotocin-induced diabetic nephropathy
  13. Pharmacognostical characterization, GC-MS profiling, and elemental analysis of Curcuma caesia Roxb. rhizomes for public health
  14. Antibacterial activity of Macrosciadium alatum (M.Bieb.) plant extract
  15. Effect of horticultural therapy on static, dynamic balance and gait speed among institutionalized older adults with cognitive impairment
  16. Anti-hyperlipidemic effects of 500 mg spilanthol (SA3X) supplementation in people with dyslipidemia – a randomized, parallel-group placebo-controlled trial
  17. Potential biomarkers of ASD a target for future treatments: oxidative stress, chemokines, apoptotic, and methylation capacity
  18. Therapeutic ayurvedic interventions for the management of rheumatoid arthritis complicated by adhesive capsulitis – a case report
Downloaded on 24.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jcim-2024-0145/html
Scroll to top button